Equity research & public-company intelligence

The primary leg reads a cluster of SEC Form 4 filings — multiple insiders accumulating their own stock, the market's clearest conviction tell. The intersect leg reads a USPTO patent assignment naming that same company as a new assignee. Insiders buying signals belief; a fresh patent signals the innovation they might be betting on — and a company doing both at once pairs conviction with a tangible catalyst. For growth and event-driven funds, that's a sourcing needle: it filters routine insider activity down to the moments where accumulation coincides with new IP being recorded. Two records — a Form 4 cluster and a patent assignment — that sit in completely different systems and rarely get read together.

The primary leg reads a cluster of SEC Form 4 filings — multiple insiders buying their own stock, the market's clearest conviction tell; the intersect leg requires the FirmStanding composite to show two or more distress markers on the same company. Insiders buying into visible strain is the contrarian signal a deep-value or turnaround desk hunts for — the people who know most accumulating exactly when the filed record says trouble. A Form 4 cluster crossed with a distress stack to find where management conviction and measurable strain coincide.

One leg reads going-concern language in an SEC filing — an auditor's substantial-doubt flag that moves slowly; the other reads an SEC Form 8-K distress item (or an NT late-filing notice), an event management had to disclose fast. Both are tells only an SEC registrant files, and both on the same registrant point the same way — a slow accounting flag and a fast disclosure corroborating each other. For a short or credit desk, that pairing is a dated, verifiable read the day the 8-K lands, not when a note comes out — two SEC records that rarely get lined up.

The primary leg reads a cluster of SEC Form 4 filings — multiple insiders accumulating their own stock; the intersect leg reads a new ClinicalTrials.gov registration from the same company. Insiders buying signals belief; a fresh trial signals the pipeline they may be betting on — and a biotech showing both at once pairs conviction with a tangible catalyst before it reaches the print. For biotech long/short and event-driven desks, that's a sourcing needle: a Form 4 cluster crossed with a trials registry to catch the names where accumulation and a new program coincide.

One leg reads a cluster of SEC Form 4 filings — multiple insiders buying their own stock; the other reads a recent FDA drug approval (Drugs@FDA) for the same company. Insiders accumulating is conviction; a fresh approval is a commercial-launch catalyst you can point to — and both on one name the day the approval hits is a corroborated long read, not a hunch. For biotech and event-driven desks, crossing a Form 4 cluster with an approvals feed isolates the moments management is buying into a real, dated catalyst.

The primary leg reads a cluster of SEC Form 4 filings — multiple insiders accumulating their own stock; the intersect leg reads fresh DOL workforce filings from the same company, proof it's hiring right now. Insiders buying is a conviction tell; live hiring is an operational one — and both on the same name pairs what management believes with what the company is actually doing. For a long or growth desk, that corroboration turns a raw insider signal into one backed by real expansion, read across a Form 4 cluster and a hiring feed.

One leg reads a cluster of SEC Form 4 filings — multiple insiders accumulating their own stock; the other reads a Phase 3 (pivotal, late-stage) program advancing on ClinicalTrials.gov for the same sponsor. Insiders buying is conviction; a Phase 3 readout is the highest-stakes catalyst in biotech — and both on one name is the sharpest long read the data assembles, management accumulating right as a pivotal trial advances. A Form 4 cluster crossed with a late-phase trial record to catch conviction meeting a make-or-break event.

The primary leg reads a cluster of SEC Form 4 filings — multiple insiders buying their own stock in the same window, the strongest open signal of management conviction. The intersect leg confirms a recent USAspending award, a funded revenue event on the books. Insiders accumulating is interesting; insiders accumulating right as new contract revenue lands is conviction backed by a catalyst you can point to. For growth-equity and corp-dev sourcing, that pairing is a needle: it separates routine insider activity from the moments where the people who know most are buying into a genuine revenue event. Two records — a Form 4 cluster and an award — that almost no one lines up together.

One leg reads an SEC Form 8-K (or an NT late-filing notice) carrying a distress item — an event management had to disclose. The other reads a year-over-year decline in plan assets on DOL Form 5500 Schedule H — a number that moves slowly and quietly. When both appear on the same company, you have a fast disclosure and a slow balance-sheet erosion pointing the same direction, a far stronger read than either in isolation. An 8-K can be a one-off; a shrinking plan can be a market year; together they're two independent stress markers corroborating each other. Restructuring and special-situations desks price that corroboration.

One leg reads an SEC Form 8-K distress item (or an NT late-filing notice) — an event management had to disclose fast; the other requires the FirmStanding composite to also show two or more independent distress markers. An 8-K can be a one-off; a multi-marker profile can build quietly; together they're a fast disclosure corroborating a subject that was already visibly strained. Restructuring and special-situations desks price exactly that corroboration — it separates the genuine wind-downs from the routine filings. A disclosure event crossed with a stacked distress profile so two independent signals confirm each other.

One leg reads a cluster of SEC Form 4 filings where multiple insiders sold in the same window — conviction turning the other way; the other reads an SEC Form 8-K distress item from the same issuer. Insiders distributing is interesting; insiders distributing right as management discloses a distress event is a signal you can act on — the balance sheet and the people who know most moving the same direction at once. For short and event-driven desks, that pairing is the needle: it separates routine insider selling from the moments it coincides with a real disclosed problem. A Form 4 cluster crossed with an 8-K that rarely get read together.

The primary leg reads a cluster of SEC Form 4 filings — multiple insiders accumulating their own stock, the market's clearest conviction tell; the intersect reads a surge in USPTO patent grants for that same company. Insiders buying signals belief; a patent surge signals the innovation they might be betting on — and a company doing both at once pairs conviction with a tangible catalyst. For growth and event-driven funds, that's a sourcing needle: it filters routine insider activity down to the moments accumulation coincides with recorded IP momentum. A Form 4 cluster crossed with the patent record, two systems that never talk.